Solid antiviral dosage forms

US9333204B2 · kind B2 · utility

Assignee

• Abb Vie Inc. · US

Inventors

• Jonathan M. Miller
• John B. Morris · Grayslake, US
• Nancy E. Sever · Northbrook, US
• Eric A. Schmitt · Libertyville, US
• Ping Gao · Portage, US
• Yi-Qun Shi · East Brunswick Township, US
• Yi Gao · Vernon Hills, US
• Bernd Liepold · Dossenheim, DE
• Anna Moosmann · Bad Sobernheim, DE
• Mirko Pauli · Ludwigshafen, DE
• Fatih Durak · Ludwigshafen, DE
• Thomas Kessler · Schifferstadt, DE
• Peter Hoelig · Wächtersbach, DE
• Karin Rosenblatt · Mannheim, DE
• Drazen Kostelac · Münstermaifeld, DE
• Rajeev Gokhale · Waukegan, US
• Mark Costello · Chicago, US
• Carl Knable · Elmhurst, US

Key dates

• Filing date: Apr 2, 2015
• Grant date: May 10, 2016
• Expiry date: Apr 2, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2300/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.